Waters Corporation (NYSE:WAT - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $279.19 and last traded at $283.58, with a volume of 224818 shares changing hands. The stock had previously closed at $290.31.
Analysts Set New Price Targets
A number of analysts have commented on WAT shares. Sanford C. Bernstein set a $400.00 price target on shares of Waters and gave the stock an "outperform" rating in a research report on Wednesday, April 16th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Waters and gave the stock a "hold" rating in a report on Tuesday. Wells Fargo & Company cut their price target on Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a report on Tuesday. Barclays reduced their price target on Waters from $400.00 to $350.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Finally, Robert W. Baird lowered their price objective on Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 16th. Ten research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Waters currently has an average rating of "Hold" and an average target price of $378.73.
View Our Latest Report on WAT
Waters Price Performance
The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.28. The stock has a fifty day moving average of $328.29 and a 200 day moving average of $352.59. The stock has a market cap of $16.55 billion, a price-to-earnings ratio of 25.02, a P/E/G ratio of 2.75 and a beta of 1.04.
Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. The business had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%. The company's revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.63 EPS. On average, analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Campbell & CO Investment Adviser LLC acquired a new position in Waters in the 2nd quarter worth about $3,477,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Waters by 6.1% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 111,572 shares of the medical instruments supplier's stock valued at $38,943,000 after buying an additional 6,427 shares in the last quarter. Fox Run Management L.L.C. acquired a new position in shares of Waters during the 2nd quarter worth approximately $254,000. Penserra Capital Management LLC lifted its position in shares of Waters by 13.1% during the 2nd quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier's stock valued at $114,000 after buying an additional 38 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. grew its stake in Waters by 6.9% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 20,509 shares of the medical instruments supplier's stock valued at $7,170,000 after acquiring an additional 1,331 shares during the period. Institutional investors and hedge funds own 94.01% of the company's stock.
About Waters
(
Get Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.